These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15883919)

  • 1. American Chemical Society - 229th National Meeting: general oral and poster sessions.
    Mackonochie M; Chan D
    IDrugs; 2005 May; 8(5):392-4. PubMed ID: 15883919
    [No Abstract]   [Full Text] [Related]  

  • 2. American Chemical Society--229th National Meeting. Kinase modulators.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):283-4. PubMed ID: 15800796
    [No Abstract]   [Full Text] [Related]  

  • 3. American Chemical Society--229th National Meeting. Oral and poster presentations.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):285-7. PubMed ID: 15800797
    [No Abstract]   [Full Text] [Related]  

  • 4. American Chemical Society - 229th National Meeting: bench to pilot plant.
    Rotella DP
    IDrugs; 2005 May; 8(5):390-1. PubMed ID: 15883918
    [No Abstract]   [Full Text] [Related]  

  • 5. American Chemical Society--229th National Meeting. Oncology.
    Chan D; Mackonochie M
    IDrugs; 2005 Apr; 8(4):280-2. PubMed ID: 15800795
    [No Abstract]   [Full Text] [Related]  

  • 6. American Chemical Society--229th National Meeting.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):277-9. PubMed ID: 15800794
    [No Abstract]   [Full Text] [Related]  

  • 7. American Chemical Society - 229th National Meeting: carbohydrate vaccines.
    Rotella DP
    IDrugs; 2005 May; 8(5):387-9. PubMed ID: 15883917
    [No Abstract]   [Full Text] [Related]  

  • 8. Anglo-Swedish Medicinal Chemistry - second symposium.
    Sarabu R
    IDrugs; 2005 May; 8(5):384-6. PubMed ID: 15883916
    [No Abstract]   [Full Text] [Related]  

  • 9. American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 2. 16-20 August 2009, Washington DC, USA.
    Gater D; Macauley D
    IDrugs; 2009 Oct; 12(10):608-11. PubMed ID: 19790005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Chemical Society 232nd national meeting. 10-14 September 2006, San Francisco, CA, USA.
    Rotella D
    IDrugs; 2006 Nov; 9(11):745-7. PubMed ID: 17096288
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 1. 16-20 August 2009, Washington DC, USA.
    Gater D; Macauley D
    IDrugs; 2009 Oct; 12(10):605-7. PubMed ID: 19790004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.
    van Poelje PD; Dang Q; Erion MD
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):430-7. PubMed ID: 17659484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV.
    Hof F; Schütz A; Fäh C; Meyer S; Bur D; Liu J; Goldberg DE; Diederich F
    Angew Chem Int Ed Engl; 2006 Mar; 45(13):2138-41. PubMed ID: 16502446
    [No Abstract]   [Full Text] [Related]  

  • 15. American Chemical Society--238th National Meeting & Exposition. Novel small molecule therapeutics. 16-20 August 2009, Washington DC, USA.
    Rotella DP
    IDrugs; 2009 Oct; 12(10):612-3. PubMed ID: 19790006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus.
    Kaur R; Dahiya L; Kumar M
    Eur J Med Chem; 2017 Dec; 141():473-505. PubMed ID: 29055870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
    van Poelje PD; Potter SC; Erion MD
    Handb Exp Pharmacol; 2011; (203):279-301. PubMed ID: 21484576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.
    Hebeisen P; Kuhn B; Kohler P; Gubler M; Huber W; Kitas E; Schott B; Benz J; Joseph C; Ruf A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4708-12. PubMed ID: 18650089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal Chemistry--30th National Symposium. 26-30 June 2006, Seattle, WA, USA.
    Massie CF
    IDrugs; 2006 Sep; 9(9):604-6. PubMed ID: 16952063
    [No Abstract]   [Full Text] [Related]  

  • 20. Foreword: American Chemical Society Division of Medicinal Chemistry. Celebrating 100 years of excellence.
    Woster PM
    J Med Chem; 2009 Dec; 52(23):7333-8. PubMed ID: 19954244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.